zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2024 / Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. for 2024 Shareholders’Meeting approved removal of the noncompete clause for directors.

Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. for 2024 Shareholders’Meeting approved removal of the noncompete clause for directors.

2024-06-14

Published Date:2024-06-14

Original Link:https://www.onenessbio.com/en/news_detail298_3.htm

No 3 Date of announcement 2024/06/14 Time of announcement 16:59:35
Subject Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. for 2024 Shareholders’Meeting approved removal of the noncompete clause for directors.
To which item it meets paragraph 21 Date of events 2024/06/14
Statement
  1. Date of the shareholders’ meeting resolution: 2024/06/14
  2. Name and title of the managerial officer with permission to engage in competitive conduct:
    1. (1)Director: Oneness biotech Co., Ltd.
    2. (2)Director: Oneness biotech Co., Ltd. Representative: Cheng, Chih-Hui
    3. (3)Director: Oneness biotech Co., Ltd. Representative: Hsu, Ching-Chang
    4. (4)Director: Oneness biotech Co., Ltd. Representative: Chang, Chih-Ming
  3. Items of competitive conduct in which the officer is permitted to engage:
    1. (1)Oneness biotech Co., Ltd.
      Director of DIAMOND BIOFUND INC.
      Director of Microbio (Shanghai) Co., Ltd.
      Director of Ihergo Inc.
      Director of Sun Biofund Inc.
      Director of Jing Ying Investment Co., Ltd.
    2. (2)Oneness biotech Co., Ltd. Representative: Cheng, Chih-Hui
      Director of DIAMOND CAPITAL INC.
      Director and Financial Officer of Microbio (Shanghai) Co., Ltd.
      Director of STEMCYTE TAIWAN CO., LTD.
      Director of StemCyte,International Ltd.
      Director of Microbio Singapore Pte. Ltd.
    3. (3)Oneness biotech Co., Ltd. Representative: Hsu, Ching-Chang
      Director and General manager of Cotton Field Organic Co.,Ltd.
      Director of Harmony Organic Agriculture Foundation
    4. (4)Oneness biotech Co., Ltd. Representative: Chang, Chih-Ming
      Independent Director of ENERGY MOANA TECHNOLOGY CO.,LTD.
  4. Period of permission to engage in the competitive conduct: Until the term expired
  5. Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act): Unanimous approval from all presented shareholders upon chairman’s inquiry.
  6. If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the directors (if it is not the operator of a mainland China enterprise, please enter “N/A” below):
    1. (1)Director: Oneness biotech Co., Ltd.
    2. (2)Institutional Director Representative: Cheng, Chih-Hui
  7. Company name of the mainland China enterprise and the officer’s position in the enterprise:
    1. (1)Oneness biotech Co., Ltd.: Director of Microbio (Shanghai) Co., Ltd.
    2. (2)Cheng, Chih-Hui: Director and Financial Officer of Microbio (Shanghai) Co., Ltd.
  8. Address of the mainland China enterprise: 1188 Guangxing Road,Songjiang District, Shanghai China.
  9. Operations of the mainland China enterprise: Drugs production, consignment production of drugs, drugs wholesale, technology development in the fields of medicine, food, and health, technical transformation, technical consultation, technical services, etc.
  10. Impact on the company’s finance and business: Microbio (Shanghai) is invested by the Company by adopting the equity method through which the profits or losses is recognized.
  11. If the directors have invested in the mainland China enterprise, the monetary amount of the investment and their shareholding ratio:
    1. (1)Oneness biotech Co., Ltd.: The monetary amount of the investment: USD 16,804,000. The shareholding ratio: 31.5%.
    2. (2)Cheng, Chih-Hui: The monetary amount of the investment: USD 372,000. The shareholding ratio: 0.7094%.
  12. Any other matters that need to be specified: None.